- Home
- ABEO vs JPI Comparison
ABEO vs JPI Comparison
Compare ABEO & JPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- JPI
- Stock Information
- Founded
- ABEO 1974
- JPI 2012
- Country
- ABEO United States
- JPI United States
- Employees
- ABEO N/A
- JPI N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- JPI Finance Companies
- Sector
- ABEO Health Care
- JPI Finance
- Exchange
- ABEO Nasdaq
- JPI Nasdaq
- Market Cap
- ABEO 256.9M
- JPI 285.8M
- IPO Year
- ABEO 1980
- JPI N/A
- Fundamental
- Price
- ABEO $5.93
- JPI $20.29
- Analyst Decision
- ABEO Strong Buy
- JPI
- Analyst Count
- ABEO 6
- JPI 0
- Target Price
- ABEO $18.00
- JPI N/A
- AVG Volume (30 Days)
- ABEO 870.0K
- JPI 54.7K
- Earning Date
- ABEO 08-11-2025
- JPI 01-01-0001
- Dividend Yield
- ABEO N/A
- JPI 6.15%
- EPS Growth
- ABEO N/A
- JPI N/A
- EPS
- ABEO N/A
- JPI N/A
- Revenue
- ABEO N/A
- JPI N/A
- Revenue This Year
- ABEO N/A
- JPI N/A
- Revenue Next Year
- ABEO $323.51
- JPI N/A
- P/E Ratio
- ABEO N/A
- JPI N/A
- Revenue Growth
- ABEO N/A
- JPI N/A
- 52 Week Low
- ABEO $3.93
- JPI $16.02
- 52 Week High
- ABEO $7.32
- JPI $19.12
- Technical
- Relative Strength Index (RSI)
- ABEO 45.53
- JPI 53.08
- Support Level
- ABEO $6.10
- JPI $20.07
- Resistance Level
- ABEO $6.24
- JPI $20.76
- Average True Range (ATR)
- ABEO 0.29
- JPI 0.27
- MACD
- ABEO -0.09
- JPI -0.03
- Stochastic Oscillator
- ABEO 4.26
- JPI 52.00
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About JPI Nuveen Preferred and Income Term Fund of Beneficial Interest
Nuveen Preferred and Income Term Fund is a closed-end management investment company. Its investment objective is to provide a high level of current income and total return. The company's products include mutual funds, closed-end funds, Exchange-traded funds, Multi-asset model portfolios, and others.